Product image of Mypaid (Dihydrocodeine Tartrate) supplied by GNH India

Mypaid

Active Ingredient:
Dihydrocodeine Tartrate
Origin:
EU

Mypaid (Dihydrocodeine Tartrate)

Dihydrocodeine tartrate, the active ingredient in Mypaid, is an opioid analgesic presented as an oral dosage form for oral use. It is indicated for the relief of moderate pain and for cough suppression in appropriate patients.

GNH India supplies Mypaid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sandoz Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mypaid is an opioid analgesic that acts on the central nervous system to alleviate pain and suppress cough.

  • Moderate pain: provides relief for conditions such as dental or musculoskeletal pain.
  • Cough: reduces the frequency and intensity of cough associated with respiratory infections.
  • Post‑operative pain: helps manage pain after minor surgical procedures.

How It Works

  • Dihydrocodeine tartrate binds to mu‑opioid receptors in the central nervous system, activating inhibitory pathways that decrease neuronal excitability. This receptor activation reduces the perception of pain and also depresses the cough reflex by acting on the medullary cough center, resulting in analgesic and antitussive effects.

Side Effects

Common Side Effects

  • Nausea: feeling of sickness or urge to vomit.
  • Constipation: reduced bowel movements and hard stools.
  • Drowsiness: increased sleepiness or fatigue.
  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Dry mouth: reduced salivation leading to a parched feeling.
  • Vomiting: expulsion of stomach contents.

Serious or Rare Side Effects

  • Respiratory depression: slowed or shallow breathing that may be life‑threatening.
  • Severe hypotension: marked drop in blood pressure.
  • Allergic reactions: rash, itching, swelling, or anaphylaxis.
  • Seizures: uncontrolled electrical activity in the brain.
  • Dependence or withdrawal: physical or psychological reliance on the drug.
  • Hepatic dysfunction: liver enzyme abnormalities or injury.

Precautions & Warnings

Before prescribing Mypaid, clinicians should evaluate patient history and potential risk factors.

  • Assess pain severity: ensure the drug is appropriate for the level of pain.
  • Avoid in respiratory depression: contraindicated for patients with compromised breathing.
  • Monitor for dependence: watch for signs of misuse or addiction.
  • Use caution in the elderly: increased sensitivity to sedative effects.
  • Avoid concomitant CNS depressants: limit use with alcohol, benzodiazepines, or other opioids.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Mypaid may interact with several medications, requiring careful management.

Major Interactions (Avoid)

  • Other opioids: additive respiratory depression risk.
  • Benzodiazepines: enhanced sedation and respiratory suppression.
  • Alcohol: increased CNS depression.
  • Central nervous system depressants: synergistic sedative effects.
  • MAO inhibitors: potential for severe hypertension.

Moderate Interactions (Monitor Closely)

  • CYP2D6 inhibitors (e.g., fluoxetine): may increase dihydrocodeine levels.
  • Anticholinergics: may exacerbate dry mouth.
  • Antihistamines: can augment drowsiness.
  • SSRIs: monitor for serotonin syndrome.
  • Diuretics: may affect blood pressure control.

Frequently Asked Questions

Mypaid contains dihydrocodeine tartrate and is prescribed to relieve moderate pain, such as dental or musculoskeletal discomfort, and to suppress cough associated with respiratory conditions. It is a prescription‑only opioid analgesic used under medical supervision.

Dihydrocodeine tartrate acts as an agonist at mu‑opioid receptors in the brain and spinal cord. Activation of these receptors reduces the transmission of pain signals and depresses the cough reflex, providing both analgesic and antitussive effects.

The appropriate dose of Mypaid is determined by the prescribing clinician based on the patient’s pain intensity, medical history, and response to therapy. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for dihydrocodeine tartrate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and only under direct medical advice.

To order Mypaid, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mypaid’s active ingredient, dihydrocodeine tartrate, offers both analgesic and antitussive properties, whereas codeine provides similar effects but may have a different potency profile. Dihydrocodeine is often considered slightly more potent than codeine for pain relief, but both share comparable safety considerations.

Mypaid should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Mypaid is taken orally, usually as a tablet, and should be swallowed whole with water unless otherwise directed by a healthcare professional. It is important to follow the prescriber’s dosing schedule and not to exceed the recommended amount.

The most serious risks include respiratory depression, severe hypotension, allergic reactions such as anaphylaxis, seizures, and the potential for dependence or withdrawal syndrome. Patients should be monitored closely for these events, especially during initiation or dose changes.

Mypaid should be avoided in individuals with known hypersensitivity to dihydrocodeine or other opioids, those with severe respiratory depression, untreated obstructive sleep apnea, or significant head injury. Caution is also advised for patients taking other central nervous system depressants.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.